Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report
Open Access
- 10 June 2020
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 21 (1), 1-5
- https://doi.org/10.1186/s12882-020-01884-9
Abstract
Background Post-transplant lymphoproliferative disease is a recognized complication following solid organ transplantation. This is usually a B cell disease and frequently associated with Epstein Barr virus infection, although T cell PTLD can occur. T cell PTLD is usually a monomorphic, lymphomatous disease associated with an adverse prognosis. Case report We report a 52 year old male pre-emptive renal transplant recipient who developed severe diarrhea with weight loss following intensification of his immunosuppression due to antibody mediated rejection 3 years after transplantation. Duodenal biopsy demonstrated monoclonal CD8+ T cell duodenitis leading to increased intraepithlieal lymphocytes and sub-total villous atrophy mimicking coeliac disease. Coeliac disease was excluded by negative anti-tissue transglutaminase antibody, HLA-DQ2 and HLA-DQ8 testing. There was no evidence of lymphoma either on biopsy or CT enterography and no FDG avid disease on PET. Symptoms did not improve with reduction of immunosuppression, but resolved fully on complete withdrawal of treatment. The transplant failed and he was established on dialysis. The diagnosis was early PTLD. Conclusions Oesophagogastroduodenoscopy with small bowel biopsies is a useful investigation for determining the cause of diarrhoea in renal transplant patients when more common causes have been excluded. This is the first report that we are aware of clonal T cell PTLD mimicking coeliac disease which only resolved after complete withdrawal of immunosuppression. As treatments for lymphoma are aggressive they are only initiated in the malignant phase and management of early stage PTLD is to minimise risk of progression by reducing immunosuppression. Any plans to retransplant will have to take into consideration the possibility that PTLD will recur.Keywords
This publication has 16 references indexed in Scilit:
- Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry studyNephrology Dialysis Transplantation, 2018
- Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatmentCancer Letters, 2015
- Mechanisms and management of refractory coeliac diseaseNature Reviews Gastroenterology & Hepatology, 2015
- Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE studyTransplantation Research, 2013
- Risk Factors and Prognosis in T-Cell Posttransplantation Lymphoproliferative DiseasesTransplantation, 2013
- The Oslo definitions for coeliac disease and related termsGut, 2012
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS GuidelinesBritish Journal of Haematology, 2010
- Classification and management of refractory coeliac diseaseGut, 2010
- REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPYThe Lancet, 1984